Inventor
DESHPANDE SHRIKANT
US14 patents
⚠️ This page may combine multiple inventors who share the name “DESHPANDE SHRIKANT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
9 patentsUS12077584B2Sep 3, 2024
Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A)
BRISTOL MYERS SQUIBB CO1 citations69
US11274150B2Mar 15, 2022
Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies
BRISTOL MYERS SQUIBB CO2 citations69
US11117968B2Sep 14, 2021
Activatable anti-CTLA-4 antibodies and uses thereof
BRISTOL MYERS SQUIBB CO2 citations69
US10556948B2Feb 11, 2020
IP-10 antibodies and their uses
BRISTOL MYERS SQUIBB CO2 citations69
US12110337B2Oct 8, 2024
Anti-CD27 antibodies and uses thereof
BRISTOL MYERS SQUIBB CO0 citations62
US12441799B2Oct 14, 2025
Activatable anti-CTLA-4 antibodies and uses thereof
BRISTOL MYERS SQUIBB CO1 citations60
US11981734B2May 14, 2024
Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)
BRISTOL MYERS SQUIBB CO0 citations59
US11708405B2Jul 25, 2023
IP-10 antibodies and their uses
BRISTOL MYERS SQUIBB CO1 citations58
US10676773B2Jun 9, 2020
Antibodies conjugatable by transglutaminase and conjugates made therefrom
BRISTOL MYERS SQUIBB CO0 citations51